Intravoxel incoherent motion imaging of the kidney: The application in patients with hyperuricemia.
hyperuricemiaIVIMrenal function
Journal
Journal of magnetic resonance imaging : JMRI
ISSN: 1522-2586
Titre abrégé: J Magn Reson Imaging
Pays: United States
ID NLM: 9105850
Informations de publication
Date de publication:
03 2020
03 2020
Historique:
received:
21
04
2019
accepted:
26
06
2019
pubmed:
19
7
2019
medline:
15
5
2021
entrez:
19
7
2019
Statut:
ppublish
Résumé
Hyperuricemia is an independent risk factor for onset and progression of kidney disease. However, there remains a lack of a reliable and noninvasive biomarker to identify and monitor the changes of renal function in patients with hyperuricemia. To assess the utility of intravoxel incoherent motion (IVIM) parameters in identifying the early changes of renal function in patients with hyperuricemia. Retrospective case-control study. Eighty-four male participants, including asymptomatic hyperuricemia (AH, 27 cases), gouty arthritis (GA, 31 cases), and 26 age-matched healthy controls. 3.0T; intravoxel incoherent motion (IVIM). Differences in the IVIM parameters among the three groups were assessed. Pure molecular diffusion (D value); perfusion-related diffusion (D* value); pseudodiffusion fraction (f value); apparent diffusion coefficient (ADC value); estimated glomerular filtration rate (eGFR). Also, they were correlated with eGFR. Bonferroni test, Tamhane's T The D values in renal cortex and medulla significantly decreased from the control, AH to GA groups (P < 0.05). The GA patients had a significantly lower cortical f value than the controls and AH patients (P < 0.05). The medullary f values in the AH and GA patients were significantly lower than that in the controls (P < 0.05). Also, the cortical and medullary ADC values had similar results across the three groups (P < 0.05), except for the comparison between the AH and GA groups (P = 0.668, P = 0.111, respectively). No significant correlation was found between any IVIM parameters with eGFR. IVIM imaging may be helpful for detecting the early changes of renal function induced by hyperuricemia. The D value could be the most sensitive IVIM-derived parameter in the assessment of renal function in patients with hyperuricemia in this study. 3 Technical Efficacy Stage: 3 J. Magn. Reson. Imaging 2020;51:833-840.
Sections du résumé
BACKGROUND
Hyperuricemia is an independent risk factor for onset and progression of kidney disease. However, there remains a lack of a reliable and noninvasive biomarker to identify and monitor the changes of renal function in patients with hyperuricemia.
PURPOSE
To assess the utility of intravoxel incoherent motion (IVIM) parameters in identifying the early changes of renal function in patients with hyperuricemia.
STUDY TYPE
Retrospective case-control study.
POPULATION
Eighty-four male participants, including asymptomatic hyperuricemia (AH, 27 cases), gouty arthritis (GA, 31 cases), and 26 age-matched healthy controls.
FIELD STRENGTH/SEQUENCE
3.0T; intravoxel incoherent motion (IVIM).
ASSESSMENT
Differences in the IVIM parameters among the three groups were assessed. Pure molecular diffusion (D value); perfusion-related diffusion (D* value); pseudodiffusion fraction (f value); apparent diffusion coefficient (ADC value); estimated glomerular filtration rate (eGFR). Also, they were correlated with eGFR.
STATISTICAL TESTS
Bonferroni test, Tamhane's T
RESULTS
The D values in renal cortex and medulla significantly decreased from the control, AH to GA groups (P < 0.05). The GA patients had a significantly lower cortical f value than the controls and AH patients (P < 0.05). The medullary f values in the AH and GA patients were significantly lower than that in the controls (P < 0.05). Also, the cortical and medullary ADC values had similar results across the three groups (P < 0.05), except for the comparison between the AH and GA groups (P = 0.668, P = 0.111, respectively). No significant correlation was found between any IVIM parameters with eGFR.
DATA CONCLUSION
IVIM imaging may be helpful for detecting the early changes of renal function induced by hyperuricemia. The D value could be the most sensitive IVIM-derived parameter in the assessment of renal function in patients with hyperuricemia in this study.
LEVEL OF EVIDENCE
3 Technical Efficacy Stage: 3 J. Magn. Reson. Imaging 2020;51:833-840.
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
833-840Informations de copyright
© 2019 International Society for Magnetic Resonance in Medicine.
Références
Zhu Y, Pandya BJ, Choi HK. Prevalence of gout and hyperuricemia in the US general population: The National Health and Nutrition Examination Survey 2007-2008. Arthritis Rheum 2011;63:3136-3141.
Trifirò G, Morabito P, Cavagna L, et al. Epidemiology of gout and hyperuricaemia in Italy during the years 2005-2009: A nationwide population-based study. Ann Rheum Dis 2013;72:694-700.
Zhang L, Wang F, Wang L, et al. Prevalence of chronic kidney disease in China: A cross-sectional survey. Lancet 2012;379:815-822.
Mortada I. Hyperuricemia, type 2 diabetes mellitus, and hypertension: An emerging association. Curr Hypertens Rep 2017;19:69-73.
Li C, Hsieh MC, Chang SJ. Metabolic syndrome, diabetes, and hyperuricemia. Curr Opin Rheumatol 2013;25:210-216.
Obermayr RP, Temml C, Gutjahr G, et al. Elevated uric acid increases the risk for kidney disease. J Am Soc Nephrol 2008;19:2407-2413.
Umekawa T, Chegini N, Khan SR. Increased expression of monocyte chemoattractant protein-1 (MCP-1) by renal epithelial cells in culture on exposure to calcium oxalate, phosphate and uric acid crystals. Nephrol Dial Transplant 2003;18:664-669.
Yu M-A, Sánchez-Lozada LG, Johnson RJ, et al. Oxidative stress with an activation of the renin-angiotensin system in human vascular endothelial cells as a novel mechanism of uric acid-induced endothelial dysfunction. J Hypertens 2010:1234-1242.
Verzola D, Ratto E, Villaggio B, et al. Uric acid promotes apoptosis in human proximal tubule cells by oxidative stress and the activation of NADPH oxidase NOX 4. PLoS One 2014;9:e115210.
Zhou X, Matavelli L, Frohlich ED. Uric acid: Its relationship to renal hemodynamics and the renal renin-angiotensin system. Curr Hypertens Rep 2006;8:120-124.
Sánchez-Lozada LG, Tapia E, Avila-Casado C, et al. Mild hyperuricemia induces glomerular hypertension in normal rats. Am J Physiol Renal Physiol 2002;283:F1105-1110.
Romi MM, Arfian N, Tranggono U, et al. Uric acid causes kidney injury through inducing fibroblast expansion, Endothelin-1 expression, and inflammation. BMC Nephrol 2017;18:326-334.
Sircar D, Chatterjee S, Waikhom R, et al. Efficacy of febuxostat for slowing the GFR decline in patients with CKD and asymptomatic hyperuricemia: A 6-month, double-blind, randomized, placebo-controlled trial. Am J Kidney Dis 2015;66:945-950.
Shlipak MG, Katz R, Sarnak MJ, et al. Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease. Ann Intern Med 2006;15:237-246.
Donnola SB, Piccone CM, Lu L, et al. Diffusion tensor imaging MRI of sickle cell kidney disease: Initial results and comparison with iron deposition. NMR Biomed 2018;31.
Le Bihan D, Breton E, Lallemand D, et al. Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology 1988;168:497-505.
Cai XR, Yu J, Zhou QC, et al. Use of intravoxel incoherent motion MRI to assess renal fibrosis in a rat model of unilateral ureteral obstruction. J Magn Reson Imaging 2016;44:698-706.
Woo S, Cho JY, Kim SY, et al. Intravoxel incoherent motion MRI-derived parameters and T2* relaxation time for noninvasive assessment of renal fibrosis: An experimental study in a rabbit model of unilateral ureter obstruction. Magn Reson Imaging 2018;51:104-112.
Feng YZ, Chen XQ, Yu J, et al. Intravoxel incoherent motion (IVIM) at 3.0 T: Evaluation of early renal function changes in type 2 diabetic patients. Abdom Radiol 2018;43:2764-2773.
Steiger P, Barbieri S, Kruse A, et al. Selection for biopsy of kidney transplant patients by diffusion-weighted MRI. Eur Radiol 2017;27:4336-4344.
Mao W, Zhou J, Zeng M, et al. Chronic kidney disease: Pathological and functional evaluation with intravoxel incoherent motion diffusion-weighted imaging. J Magn Reson Imaging 2018;47:1251-1259.
Neogi T, Jansen TL, Dalbeth N, et al. 2015 Gout classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 2015;74:1789-1798.
Kong X, Ma Y, Chen J, et al. Evaluation of the Chronic Kidney Disease Epidemiology Collaboration equation for estimating glomerular filtration rate in the Chinese population. Nephrol Dial Transplant 2013;28:641-651.
Koka RM, Huang E, Lieske JC. Adhesion of uric acid crystals to the surface of renal epithelial cells. Am J Physiol Renal Physiol 2000;278:F989-998.
Preitner F, Laverriere-Loss A, Metref S, et al. Urate-induced acute renal failure and chronic inflammation in liver-specific Glut9 knockout mice. Am J Physiol Renal Physiol 2013;305:F786-F795.
Heijnen LA, Lambregts DM, Mondal D, et al. Diffusion-weighted MR imaging in primary rectal cancer staging demonstrates but does not characterise lymph nodes. Eur Radiol 2013;23:3354-3360.
Marilda M, Kanellis J, Han L, et al. Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism. Am J Physiol Renal Physiol 2002;282:F991-997.
Paul BJ, Anoopkumar K, Krishnan V. Asymptomatic hyperuricemia: Is it time to intervene? Clin Rheumatol 2017;36:2637-2644.
Sánchez-Lozada LG, Tapia E, Santamaría J, et al. Mild hyperuricemia induces vasoconstriction and maintains glomerular hypertension in normal and remnant kidney rats. Kidney Int 2005;67:237-247.
Weiner DE, Tighiouart H, Elsayed EF, et al. Uric acid and incident kidney disease in the community. J Am Soc Nephrol 2008;19:1204-1211.
Henkelman RM. Does IVIM measure classical perfusion? Magn Reson Med 1990;16:470-475.
Henkelman RM, Neil JJ, Xiang QS. A quantitative interpretation of IVIM measurements of vascular perfusion in the rat brain. Magn Reson Med 1994;32:464-469.
Liu Z, Xu Y, Zhang J, et al. Chronic kidney disease: Pathological and functional assessment with diffusion tensor imaging at 3T MR. Eur Radiol 2015;25:652-660.
Su J, Li SJ, Chen ZH, et al. Evaluation of podocyte lesion in patients with diabetic nephropathy: Wilms' tumor-1 protein used as a podocyte marker. Diabetes Res Clin Pract 2010;87:167-175.
Sigmund EE, Vivier PH, Sui D, et al. Intravoxel incoherent motion and diffusion-tensor imaging in renal tissue under hydration and furosemide flow challenges. Radiology 2012;263:758-769.
Ichikawa S, Motosugi U, Ichikawa T, et al. Intravoxel incoherent motion imaging of the kidney: Alterations in diffusion and perfusion in patients with renal dysfunction. Magn Reson Imaging 2013;31:414-417.
Gaudiano C, Clementi V, Busato F, et al. Diffusion tensor imaging and tractography of the kidneys: Assessment of chronic parenchymal diseases. Eur Radiol 2013;23:1678-1685.
Sánchez-Lozada LG, Tapia E, López-Molina R, et al. Effects of acute and chronic L-arginine treatment in experimental hyperuricemia. Am J Physiol Renal Physiol 2007;292:F1238-1244.
Zöllner FG, Svarstad E, Munthe-Kaas AZ, et al. Assessment of kidney volumes from MR Images: Acquisition and segmentation techniques. Am J Roentgenol 2012;199:1060-1069.